141名の方が先月見積もりをリクエストしました
Bulent Karagoz
- 5 優秀 • 4 レビュー
- 33年の経験
- 所在地: トルコ, イスタンブール
ビュレント・カラゴズ教授は、アナドル医療センターにて免疫療法および分子標的療法を用いた肺癌治療を専門としています。
- 腫瘍内科における33年の経験年以上の臨床経験
- 腫瘍生物学および免疫学の専門家
- イスタンブール・オカン大学医学部教授
- がん研究分野における40件以上の論文著者
- トルコ腫瘍内科学会会員
- 続きを読む
トルコのトップ肺癌医師と価格を比較。こちらで最適なマッチングを見つけてください
ご要望と予算に基づいて最適な医師を厳選いたします
医学的監修者 Fahad Mawlood
医学編集者・データサイエンティストトップ医師
62
トルコ
レビュー
14000+
実際の患者より
個別化された治療計画を無料で取得し、最良のオプションを選択してください。コミットメント不要 · サービス料金なし
最初に表示:
141名の方が先月見積もりをリクエストしました
ビュレント・カラゴズ教授は、アナドル医療センターにて免疫療法および分子標的療法を用いた肺癌治療を専門としています。
55名の方が先月見積もりをリクエストしました
エダ・タンリクル・シムシェク教授は900件以上の処置を行っており、アナドル医療センターにて腫瘍内科を専門としています。
32名の方が先月見積もりをリクエストしました
20年の経験 腫瘍内科医として — ソラク医師はヒサール病院インターコンチネンタルにて肺癌を専門としています。
40名の方が先月見積もりをリクエストしました
11名の方が先月見積もりをリクエストしました
Assoc. Prof. Gorkem Turkkan started his medical education at Gülhane Military Medical Academy in 2003 and completed it at Zonguldak Karaelmas (Bülent Ecevit) University Faculty of Medicine in 2009. He completed his specialization at Trakya University Faculty of Medicine, Department of Radiation Oncology and became a radiation oncology specialist in 2016.
After completing his compulsory service, he served as a Lecturer and Head of Department at Muğla Sıtkı Koçman University Faculty of Medicine, Department of Radiation Oncology, from May 2019 to February 2021. Meanwhile, between March and June 2020, he worked as a clinical researcher at Maastricht University Faculty of Medicine Department of Radiation Oncology – MAASTRO Clinic (Netherlands) on stereotactic radiotherapy, thoracic radiotherapy-related lung toxicity and proton therapy. While he was working at İstinye University Faculty of Medicine, Department of Radiation Oncology and Liv Hospital Ulus Radiation Oncology Clinic between March 2021 and April 2023, he received the title of Associate Professor in February 2023. She has been serving her patients at Hisar Hospital Intercontinental since May 2023.
He has performed both traditional radiotherapy and advanced radiotherapy throughout his career. He is one of the experienced physicians in our country in stereotactic radiotherapy and MRI-guided radiotherapy treatments, which have become increasingly popular and used especially recently. So far, he has successfully completed more than 2500 radiotherapy sessions with the MR-Linac device.
He has been a member of the Turkish Society of Radiation Oncology (TROD) since 2013 and the European Society of Radiotherapy and Oncology (ESTRO) since 2015. He has 27 articles published in domestic and international journals, 31 oral-poster presentations presented at national and international congresses, and 5 book chapters published by national and international publishing houses. He taught Term I and Term V undergraduate courses at Muğla Sıtkı Koçman University Faculty of Medicine, postgraduate courses within the scope of Ear Nose and Throat Department Specialization training, and Radiotherapy associate degree courses at İstinye University Vocational School of Health Services. She is currently working on 2 ongoing TÜBİTAK Projects. He is married and has a son.
MEDICAL INTERESTS
MR-Linac
Linac
Stereotactic (Pinpoint) Radiotherapy
Prostate Cancers
Breast Cancers
Lung Cancers
Rectum Cancers
Brain and Spinal Cord Cancers
Head and Neck Cancers
Volumetric Arc Therapy (VMAT)
Intensity Modulated Radiotherapy (IMRT)
Dr. Banu Atalar is a board-certified radiation oncologist (Türkiye, 2004). She is a Full Professor at Acibadem MAA University (2018–present) and a clinician at Anadolu Medical Center (2026–present). She trained at Istanbul and Cerrahpaşa. In 2011, she completed a Stanford clinical research fellowship in stereotactic radiosurgery. Her practice focuses on CNS, thoracic, and GI tumors. About 75% of her care involves SRS and MR‑guided adaptive SRS.
Her honors include the ASCO IDEA award (2004), the IASLC International Mentorship Award (2018), and H.FACR (2025). She has 72 international peer‑reviewed publications. Her leadership roles include President of the Turkish Society for Radiation Oncology (2025–27) and Chair of the ESTRO National Societies Committee (2024–27). She served on the ASCO Resource‑Stratified Guidelines Committee (2013–18) and on RSS meeting and nomination committees. She organized national congresses (2023, 2025) and has been an invited speaker at major meetings.
Prof. Hüseyin Baloğlu is a pathology specialist at Anadolu Medical Center in Gebze, Kocaeli, Turkey. He focuses on molecular pathology, surgical pathology, and tumour biopsy and diagnostics.
Education and accreditations: MD, GATA Medical School (1986). Pathology specialty training, GATA (1992). Associate Professor (Doçent), GATA (2004). Visiting scholar at Albert Einstein College of Medicine (New York) and Heidelberg University.
Achievements: author of over 600 peer‑reviewed publications. Holds a patent in molecular diagnostics for thyroid cancer. Leads liquid biopsy and precision oncology services.
Personal Information
Sex: Male
Born : 1968
Professional Experience
Gayrettepe Florence Nigthingale Hospital
Medical Oncology Department
Besiktas/Istanbul/Turkey (ongoing)
Education:
He became Professor (22/April /2016)
Medical Oncology
Attending Phys.in Gastrointestinal Oncology (January 2005 ,2009)
Istanbul University Oncology Institue,
Department of Medical Oncology
Medical Oncology Fellowship (December 2001-December2004)
Istanbul University, Istanbul Medical Faculty
Hemodialysis Traning (May1996-January1997)
Istanbul University ,bCerrahpasa Medical Faculty
Internal Medicine Residency (November 1991-November 1996)
Istanbul University ,bCerrahpasa Medical Faculty
Ege University Medical Faculty (1985-1991)
Professional Experience
February 1999-November 2001
Metropolitan Florence Nigthingale Hospital
American Cancer Center, Gayrettepe/İstanbul
April1997- October 1998
Bayraktar Dialysis Center
Güngören/ Istanbul
Membership
Turkish Medical Oncology Association
ENET(European Neuroendocrine Tumour Society)
ESMO
ASCO
Education and Specialization
Work Experience
Expertise
Personal information
Title: Professor Doctor
Branch: Radiation Oncology
Work History:
1 GATA Military Medical Faculty
2 Gayrettepe Florence Nightingale Hospital
3 T.R. Demiroğlu Bilim University \ Associate Professor
4 T.R Demiroğlu Bilim University \ Professor
Medical Specialties and Subspecialties:
1 Head and Neck Cancers
2 Radiation Oncology
Priority treatments:
1 Prostate cancer
2 Conformal treatments
Special advanced health technologies:
1 Truebeam Stx Technology
2 Halcyons
Education
1991 - Istanbul University Istanbul Faculty of Medicine
1996 - Istanbul University Cerrahpaşa Faculty of Medicine Radiation
Oncology Specialization Training
Experience
2022 PRIVATE MEDIPOL BAHÇELİEVLER HOSPITAL
2021 - 2021 Prof. Dr. Cemil Taşçıoğlu City Hospital, Medical Oncology Clinic Education Officer
2021 - 2021 Prof. Dr. Cemil Taşçıoğlu City Hospital
2020 - 2021 Yüzüncü Yıl University Faculty of Medicine
2020 - 2021 Head of the Department of Medical Oncology, Yüzüncü Yıl University Faculty of Medicine, Assoc. Dr.
2018 - 2021 Lecturer - Yüzüncü Yıl University Faculty of Medicine, Head of Medical Oncology Department
2018 - 2021 Yüzüncü Yıl University Faculty of Medicine
2015 - 2018 University of Health Sciences, Okmeydanı Training and Research Hospital
2015 - 2018 University of Health Sciences, Okmeydanı Training and Research Hospital, Medical Oncology Clinic, Sub-branch assistant
2012 - 2015 Kanuni Sultan Süleyman Training and Research Hospital, Internal Medicine specialist
2012 - 2015 Suleiman the Magnificent Training and Research Hospital,
2008 - 2012 Haseki Training and Research Hospital
2006 - 2008 Kızıltepe No. 3 Health Center General Practitioner.
Education
2018
İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbı Onkoloji
2018
İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbı Onkoloji, İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbı Onkoloji
2012
İstanbul Haseki Eğitim ve Araştırma Hastanesi, İç Hastalıkları, İstanbul Haseki Eğitim ve Araştırma Hastanesi, İç Hastalıkları
2012
İstanbul Haseki Eğitim ve Araştırma Hastanesi, İç Hastalıkları
2007
Uludağ Üniversitesi Tıip Fakültesi, Tıip Fakültesi, Uludağ Üniversitesi Tıip Fakültesi, Tıip Fakültesi
44名の方が先月見積もりをリクエストしました
シナン・カラアスラン博士は、乳がん、大腸がん、泌尿生殖器系がんの管理において最高の腫瘍医の一人です。
32名の方が先月見積もりをリクエストしました
Serkan Keskin教授は、メモリアル・シシリ病院において化学療法を専門とし、25年の経験年の腫瘍学経験を持ち、1,100件以上の処置を行ってきました。
シェレフ・コミュルジュ教授は、がん管理に関する110本以上の論文を執筆しており、アナドル医療センターにて肺がんを専門としています。
イェシム・イルドゥルム教授は、肺癌の免疫療法および分子標的治療を専門とし、アナドル医療センターにおいて臨床的専門知識と学術研究を融合させています。
16名の方が先月見積もりをリクエストしました
Dr. Rahib Hasanov is a medical oncologist. He graduated from Istanbul University Cerrahpaşa Faculty of Medicine (1999–2005). He completed an internal medicine residency (2009–2013) and a medical oncology fellowship at Marmara University (2015–2018). He also completed an observership at Houston Methodist Hospital (2006–2007).
He focuses on personalized oncology. His treatments include immunotherapy, targeted therapy, and novel agents. His clinical interests include gastrointestinal, breast, lung, and genitourinary cancers.
He attends national and international conferences. He welcomes patients from Turkey, Azerbaijan, Montenegro, Georgia, Uzbekistan, the Middle East, Europe, and the United States.
アルタン・クル教授は胸部外科およびロボット手術の専門家です。彼はまた、肺がんのトップ医師の1人でもあります。教授は2007年からアナドール医療センターで胸部外科医として働いています。
メンバーシップ
カラデニズ大学医学部、トラブゾン 1984
胸部外科専門教育、ディヤルバクルのディッチェ大学医療学部、1991
ロンドン・ロイヤル・ブロンプトン病院、ロンドン 1996
ニューヨーク記念スローン・ケタリングがんセンター、ニューヨーク、1999
専門分野
Prof. Dr. Sezer Sağlam is a medical oncologist at Gayrettepe Florence Nightingale Hospital. He specializes in gastrointestinal and breast cancers. He has contributed to cancer care through research, especially with his study on the best timing for surgery after neoadjuvant therapy in rectal cancer. This work has influenced global treatment protocols.
Dr. Sağlam has led clinical trials in targeted therapies and precision medicine. His research on liver-transplanted patients with hepatocellular carcinoma was nominated for the 2024 International Best Researcher Award. He is a member of ASCO, ESMO, and ENET. Dr. Sağlam provides personalized and evidence-based oncology care.
この医師は、トルコのいくつかの著名な病院で豊富な経験を持つベテランの医療腫瘍学者であり、2019年からMemorial Bahçelievler Hospitalに勤務しています。Cerrahpasa Faculty of Medicineで医学の学位を取得し、Sisli Etfal Training and Research Hospitalで内科のレジデンシーを修了し、Istanbul Bilim Universityで医療腫瘍学のレジデンシーを修了しました。2016年に准教授の地位を達成し、医療腫瘍学の分野で20以上の論文と10の書籍の章を執筆しています。
2012年にトルコ医療腫瘍学会から腫瘍研究賞を受賞し、ヨーロッパ医療腫瘍学会を含む複数の専門学会の積極的なメンバーです。
62名の医師のうち19名をご覧いただきました
海外のクリニックを選ぶことはストレスフルです。800,000名以上の患者をサポートしたBookimedは、お客様の懸念を理解しています。信頼できる医師、最高の価格品質オプション、複雑なケースの解決策を見つける方法を知っています。すべての段階でお客様をご案内いたします。
ヤン・マツィイフスキー
医療コーディネーターチーム責任者
4300+件以上の患者の旅をガイド
Bookimedで3年
Turkeyの278名の患者が今月当社を通じて医師を見つけました
2分のクイズ
目標、予算、スケジュールをお聞かせください
人間のマッチング + AI
アルゴリズムがマッチングを見つけ、コーディネーターが適合性を確認します
オプション準備完了
価格、パッケージ、日程を比較。コーディネーターとチャット
選択肢に迷っていますか?
治療をガイド
医療訓練を受けた専属コーディネーター






| 順位 | 医師 | 経験 | 適合する方 | 特色 | クリニックと所在地 | 診察 |
|---|---|---|---|---|---|---|
| #1 | 33年の経験 | 免疫療法および分子標的療法 | 免疫療法や分子標的療法などの最先端肺癌治療を専門とする。腫瘍内科学において豊富な研究実績と指導的立場を有する教授。 | トルコ | から $215 | |
| #2 | 21年の経験 | 進行肺癌症例 | 腫瘍内科を専門とし、900件以上の処置を実施。主要な研修病院において腫瘍内科部長を歴任。国際学術誌への研究論文掲載実績あり。 | トルコ | から $215 | |
| #3 | 20年の経験 | 肺癌症例 | 肺癌を専門とし、ハジェテペ大学癌研究所でフェローシップ研修を修了。腫瘍学の世界的権威であるMDアンダーソン癌センターに勤務。 | トルコ | から $100 | |
| #4 | 25年の経験 | 高度化学療法 | 全国腫瘍学試験で首位を獲得し、分子標的療法を専門とする。ASCO・ESMOの会員であり、1,100件以上の処置を実施した受賞歴のある研究者。 | トルコ | から $150 | |
| #5 | 33年の経験 | 進行性肺癌 | 複雑な肺癌症例を専門とし、豊富な研究歴を有する。ESMO認定を取得し、主要な医学アカデミーの教授を務める。 | トルコ | から $215 | |
| #6 | 22年の経験 | 免疫療法と分子標的療法 | 肺癌免疫療法のパイオニアであり、ESMO認定を取得。80件以上の論文発表を通じて、国際的な癌治療ガイドラインの策定に貢献。 | トルコ | から $215 |
Top-rated lung cancer specialists in Turkey include Prof. Dr. Altan Kır and Prof. Dr. Bülent Karagöz. These experts hold international fellowships from centers like Memorial Sloan Kettering. They specialize in robotic thoracic surgery and advanced immunotherapy to improve patient survival and recovery times.
Bookimed Expert Insight: Patients often find higher value at Anadolu Medical Center due to its Johns Hopkins partnership. This collaboration means Turkish specialists follow the same strict treatment protocols used in top American hospitals. Our data shows this consistency often leads to better managed complex cases compared to smaller clinics.
Patient Consensus: Patients often mention feeling relieved because the medical teams handle everything from the first scan. One person noted the doctors take time to explain how robotic surgery reduces pain and scarring.
Turkish lung cancer specialists complete over 10 years of training. They hold board certifications from bodies like the European Society for Medical Oncology. Many serve as professors. This ensures they use the latest research to plan your care. These experts often complete fellowships at top American or European hospitals.
Bookimed Expert Insight: Top Turkish specialists often hold dual certifications from European and Turkish medical boards. We see that doctors with professor titles at university-affiliated hospitals frequently lead multidisciplinary teams. This setup ensures that surgeons and oncologists coordinate closely on complex cases. This collaboration is vital for combining surgery with modern immunotherapy effectively.
Patient Consensus: Patients often mention how clearly doctors explains complex steps like VATS, a type of minimally invasive surgery. They feel reassured when specialists take time to review scans in person. Many noticed that translators and medical teams work together to make the hospital stay smooth.
Turkish doctors use the latest lung cancer treatments, including robotic surgery and targeted therapies. Many specialists hold memberships in the American Society of Clinical Oncology (ASCO). They often train in Europe or the U.S. to master advanced methods like video-assisted thoracoscopic surgery (VATS).
Bookimed Expert Insight: Turkish specialists provide rapid access to immunotherapy drugs like pembrolizumab, which can take weeks elsewhere. This speed is vital because lung cancer can progress quickly without immediate medical intervention. Most top-rated oncologists in Istanbul work within JCI-accredited systems that prioritize multidisciplinary tumor boards for every case.
Patient Consensus: Patients often mention how quickly doctors move from the first consultation to the start of treatment. One person noted they felt relieved because the hospital handled all logistics and language needs. Many were surprised that they could start advanced radiation therapy within days of arriving at the clinic.
You can see a lung cancer doctor in Turkey within 48 hours for initial consultations. Most patients start intensive treatment or complex surgery within 3 to 5 days of arrival. Private clinics eliminate waiting lists so therapy can begin almost immediately after the first evaluation.
Bookimed Expert Insight: Top specialists in Turkey, such as those at Memorial or Anadolu, use multidisciplinary tumor boards. These boards meet multiple times weekly to review cases. This means a surgeon, oncologist, and radiologist can approve your plan in a single day.
Patient Consensus: Patients were surprised by how fast they moved from the airport to the hospital room. They noted that Bookimed handled the logistics, so they focused only on their recovery.
During your first consultation, ask about biomarker testing to identify specific mutations in your tumor. Top Turkish specialists use these results to select targeted therapies or immunotherapy for better results. This helps doctors create a personalized plan rather than using a one-size-fits-all approach.
Bookimed Expert Insight: Specialists at Anadolu Medical Center often follow protocols from Johns Hopkins Medicine. These experts typically prioritize liquid biopsies to monitor cancer without needing invasive tissue samples during follow-ups. Choosing doctors with such international affiliations means your treatment aligns with research-backed global benchmarks.
Patient Consensus: Patients were surprised by how thoroughly doctors reviewed their previous imaging. They felt relieved when translators handled all medical communication, allowing them to focus on recovery.